USFDA conducted an audit of Jeevan Scientific Technology Ltd's clinical pharmacology Centre, Hyderabad. The purpose of this audit was to review the BA/BE studies. The auditors started the review on 15th April, 2019 and completed on 24th April, 2019.
The auditors completed the audit with NIL Observation (i.e. zero 483 observation), signifying that best practices were followed, in compliance to applicable regulations.
Shares of Jeevan Scientific Technology Ltd was last trading in BSE at Rs.30.35 as compared to the previous close of Rs. 28.95. The total number of shares traded during the day was 10794 in over 19 trades.
The stock hit an intraday high of Rs. 32 and intraday low of 28. The net turnover during the day was Rs. 303463.